Daily Briefing · 2026-11-02

Anthropic's revenue surged over eleven hundred percent, but soaring computing infrastructure costs offset the growth entirely, leaving net profit at zero. MarketWatch reported that slowing earnings growth projected for 2027 poses the biggest threat to the current AI-driven stock market rally built on strong 2026 corporate profits. Oracle shares fell after the company detailed a plan to raise 20 billion dollars, with investors citing concerns about dilution and the financial burden of funding AI cloud infrastructure expansion. Commentary on the October FOMC meeting pointed to the next policy decision not arriving until December. Intel's roughly 30 percent stock collapse prompted an analyst rating upgrade, with the analyst citing improved valuation metrics and potential recovery opportunities. An analyst upgraded KLA, pointing to rising chip complexity as a driver of increasing demand for the company's equipment. SK hynix's third-quarter inventory buildup signals persistent memory chip oversupply, pointing to continued pricing pressure and margin compression despite industry recovery hopes. SpaceX is reportedly targeting Boost Mobile for a potential acquisition as it seeks to capture a share of a 1 trillion dollar cellular revenue opportunity. Seeking Alpha reported that while a Democratic-controlled Congress could not directly ban Bitcoin, it could impose regulations on financial intermediaries that would significantly restrict cryptocurrency accessibility and adoption. Seeking Alpha published ongoing coverage examining the factors behind gold's recent price selloff. New Apple CEO John Ternus faces pressure to show financial resilience while navigating rising memory costs and softening consumer spending heading into earnings. General Dynamics posted a record 220.3 billion dollar backlog in the third quarter, positioning the defense contractor for significant future revenue growth. IDEXX Laboratories' third-quarter revenue grew 8 percent year-over-year to 813 million dollars, with net income rising 12 percent to 127 million dollars amid moderating organic growth in veterinary diagnostics. Axsome Therapeutics posted strong third-quarter revenue growth driven by increased sales of its psychiatric and neurology medications, resulting in margin expansion and improved full-year guidance. CNA Financial Corporation posted third-quarter results showing improved operational performance. Capital Power Corporation generated 338 million dollars in adjusted EBITDA in the third quarter, reflecting stable operational performance despite challenging market conditions. Sumitomo Chemical posted second-quarter net income of 12.8 billion yen on revenue of 412.3 billion yen, a 15 percent year-over-year increase in profitability driven by its agricultural chemicals and plastics divisions. The Financial Times reported that voter backlash tied to high living costs during the Trump administration's building initiatives threatens to weigh on consumer sentiment, with potential knock-on effects for tax revenues and economic growth.